02 Mar 2020 --- The combination of Bifidobacterium infantis, Bifidobacterium lactis and Streptococcus thermophilus included in Chr Hansen’s probiotic strain blend has been recommended by the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) as effective in reducing the intestinal disease necrotizing enterocolitis (NEC) in preterm babies. This recommendation comes just three months after Chr. Hansen launched its probiotic blend that is touted for helping preterm babies develop healthy intestines and reducing the risk of NEC by up to 50 percent.
